This study is looking at whether a marijuana-based compound called MB-IMP can help reduce anxiety in autistic adults. MB-IMP is an oil-based liquid you take by mouth, and it has mostly CBD with a small amount of THC. Researchers will compare MB-IMP to a placebo (a substance that looks the same but has no active ingredients) to see if it improves anxiety symptoms over 8 weeks. You might be able to join if you are an autistic adult between 18 and 45 years old, weigh at least 100 lbs, and are willing to follow study procedures. The study aims to enroll 108 participants, but its current recruitment status is unclear.

Study design

This is an interventional study comparing MB-IMP to a placebo, with a planned enrollment of 108 participants. It is not specified if participants or researchers will know who is receiving MB-IMP versus placebo.

What's involved

You would take MB-IMP or a placebo orally once or twice a day for 8 weeks and keep a daily diary. There is a 3-week screening period, and one follow-up visit 14 days after stopping the study drug.

Compensation

Not stated in the trial record.

Follow-up

There will be one follow-up visit 14 days after you stop taking the study drug.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.